These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16580971)

  • 1. Orphan enzymes could be an unexplored reservoir of new drug targets.
    Lespinet O; Labedan B
    Drug Discov Today; 2006 Apr; 11(7-8):300-5. PubMed ID: 16580971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ORENZA: a web resource for studying ORphan ENZyme activities.
    Lespinet O; Labedan B
    BMC Bioinformatics; 2006 Oct; 7():436. PubMed ID: 17026747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puzzling over orphan enzymes.
    Lespinet O; Labedan B
    Cell Mol Life Sci; 2006 Mar; 63(5):517-23. PubMed ID: 16465439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemogenomic analysis of the human proteome: application to enzyme families.
    Bernasconi P; Chen M; Galasinski S; Popa-Burke I; Bobasheva A; Coudurier L; Birkos S; Hallam R; Janzen WP
    J Biomol Screen; 2007 Oct; 12(7):972-82. PubMed ID: 17942790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of orphan enzyme activities.
    Pouliot Y; Karp PD
    BMC Bioinformatics; 2007 Jul; 8():244. PubMed ID: 17623104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.
    Hodawadekar SC; Marmorstein R
    Oncogene; 2007 Aug; 26(37):5528-40. PubMed ID: 17694092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic basis of enzyme-targeted drugs.
    Robertson JG
    Biochemistry; 2005 Apr; 44(15):5561-71. PubMed ID: 15823014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation chemical proteomic tools for rapid enzyme profiling.
    Uttamchandani M; Lu CH; Yao SQ
    Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme genomics: Application of general enzymatic screens to discover new enzymes.
    Kuznetsova E; Proudfoot M; Sanders SA; Reinking J; Savchenko A; Arrowsmith CH; Edwards AM; Yakunin AF
    FEMS Microbiol Rev; 2005 Apr; 29(2):263-79. PubMed ID: 15808744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging bacterial enzyme targets.
    Su Z; Honek JF
    Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Query generation to search for inhibitors of enzymatic reactions.
    Reitz M; von Homeyer A; Gasteiger J
    J Chem Inf Model; 2006; 46(6):2333-41. PubMed ID: 17125177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Representativity of target families in the Protein Data Bank: impact for family-directed structure-based drug discovery.
    Mestres J
    Drug Discov Today; 2005 Dec; 10(23-24):1629-37. PubMed ID: 16376823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting enzyme function from protein sequence.
    Minshull J; Ness JE; Gustafsson C; Govindarajan S
    Curr Opin Chem Biol; 2005 Apr; 9(2):202-9. PubMed ID: 15811806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential implications of availability of short amino acid sequences in proteins: an old and new approach to protein decoding and design.
    Otaki JM; Gotoh T; Yamamoto H
    Biotechnol Annu Rev; 2008; 14():109-41. PubMed ID: 18606361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Call for an enzyme genomics initiative.
    Karp PD
    Genome Biol; 2004; 5(8):401. PubMed ID: 15287973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
    Dougherty TJ; Miller PF
    IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.